Content
Jade Biosciences
completed $80 million Venture Round funding. Investors include
Venrock (lead), Fairmount Funds Management (lead), Braidwell, Deep Track Capital, Driehaus Capital Management, Franklin Templeton, RTW Investments.
About
Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications.
Startup
Sector:
Biotech
Life Science
Download StockFan App
Ad
Stock market data, news and community, all integrated.


Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
